CDER’s latest proposal to withdraw the accelerated acceptance of Makena (HPC) was primarily based upon a substantial randomized trial that failed to confirm the benefit of this drug to newborns or decrease the https://delilaheqpq117298.wikirecognition.com/844613/mkena_com_an_overview